Cargando…

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines

Detalles Bibliográficos
Autor principal: Kremer, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546260/
https://www.ncbi.nlm.nih.gov/pubmed/33065038
http://dx.doi.org/10.1016/j.ymthe.2020.10.002
_version_ 1783592194819489792
author Kremer, Eric J.
author_facet Kremer, Eric J.
author_sort Kremer, Eric J.
collection PubMed
description
format Online
Article
Text
id pubmed-7546260
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-75462602020-10-13 Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines Kremer, Eric J. Mol Ther Editorial American Society of Gene & Cell Therapy 2020-11-04 2020-10-09 /pmc/articles/PMC7546260/ /pubmed/33065038 http://dx.doi.org/10.1016/j.ymthe.2020.10.002 Text en © 2020 The American Society of Gene and Cell Therapy.
spellingShingle Editorial
Kremer, Eric J.
Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
title Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
title_full Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
title_fullStr Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
title_full_unstemmed Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
title_short Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
title_sort pros and cons of adenovirus-based sars-cov-2 vaccines
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546260/
https://www.ncbi.nlm.nih.gov/pubmed/33065038
http://dx.doi.org/10.1016/j.ymthe.2020.10.002
work_keys_str_mv AT kremerericj prosandconsofadenovirusbasedsarscov2vaccines